Tofacitinib
Product Specifications
CAS Number
477600-75-2
Target
Apoptosis|||ROCK|||JAK|||Src
Related Pathways
Cell Cycle/Checkpoint|||JAK/STAT signaling|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Angiogenesis|||Stem Cells|||Apoptosis
Purity
>99.99%
Bioactivity
Tofacitinib (Tasocitinib) is a Janus kinase inhibitor that inhibits JAK3/2/1 (IC50=1/20/112 nM) and is orally active. Tofacitinib is used for the treatment of moderate to severe rheumatoid arthritis.
Smiles
C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N
Molecular Formula
C16H20N6O
Molecular Weight
312.37
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![CBR1, ID (Carbonyl Reductase [NADPH] 1, NADPH-dependent Carbonyl Reductase 1, Prostaglandin-E (2) 9-reductase, Prostaglandin 9-ketoreductase, 15-hydroxyprostaglandin Dehydrogenase [NADP+], CBR, CRN) (MaxLight 490) discontinued](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
C1146-02B-ML490 100 µL
CBR1, ID (Carbonyl Reductase [NADPH] 1, NADPH-dependent Carbonyl Reductase 1, Prostaglandin-E (2) 9-reductase, Prostaglandin 9-ketoreductase, 15-hydroxyprostaglandin Dehydrogenase [NADP+], CBR, CRN) (MaxLight 490) discontinued
Ask
View Details 
I7662-93E-FITC 200 µL
IRF8, CT (Interferon Regulatory Factor 8, IRF-8, Interferon Consensus Sequence-binding Protein, ICSBP, IRF8, ICSBP1) (FITC) discontinued
Ask
View Details GTR15089940 1 Vial
Lentiviral human CLIC4 shRNA (UAS) - Lentiviral human CLIC4 shRNA (UAS, RFP) (100)
Ask
View Details